Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor

Ann Am Thorac Soc. 2024 Feb;21(2):360-362. doi: 10.1513/AnnalsATS.202308-735RL.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminophenols / adverse effects
  • Benzodioxoles*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Forced Expiratory Volume
  • Humans
  • Indoles*
  • Mutation
  • Pyrazoles*
  • Pyridines*
  • Pyrrolidines*
  • Quinolones*

Substances

  • elexacaftor
  • ivacaftor
  • tezacaftor
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Aminophenols
  • Benzodioxoles
  • Indoles
  • Pyrazoles
  • Pyridines
  • Pyrrolidines
  • Quinolones